Search
The COVID-19 pandemic made it abundantly clear that a better understanding of emerging viruses and their variants is of great importance to society. Mathias Munschauer from the Helmholtz Institute Würzburg [...] Mathias Munschauer created the first…
called LEOPARD. Unlike established medical testing methods, such as the standard PCR tests used in the COVID-19 pandemic, this technique provides much more information. In the future, LEOPARD can thus help doctors
LEOPARD – a new technology that has the potential to revolutionize medical diagnostics not only of Covid-19, but also of tuberculosis, sepsis or rare genetic diseases. Learn more about LEOPARD Learn more
called LEOPARD. Unlike established medical testing methods, such as the standard PCR tests used in the COVID pandemic, the new technique provides much more information. In the future, LEOPARD can thus help doctors
Just appointed
News
Germany, including Charité, RKI, and MDC in Berlin and RWTH Aachen—has helped to understand why severe COVID-19 patients require prolonged ventilation. More about Emmanuel Saliba Locating the hiding places of
infectious disease. In this context, Saliba uses the example of gastrointestinal pathogens and long COVID: “Some bacteria and viruses can hide inside our own immune cells and there they can survive therapies [...] the past three years, the Saliba lab…
Technology
Page
selected single-cell analysis as the breakthrough of the year in 2018. Covid-19 Lung Macrophages Macrophages found in a patient with Covid-19. RGL model. Saliba lab, © HIRI, Oliver Dietrich Conducting research
After remote starts and quarantine due to the COVID-19 pandemic, Elise Bornet (France), Sebastian Zielinski (Germany) and Marco Olguin (Mexico) have just begun their PhD journey at HIRI. Elise joins us
Würzburg. Originally planned for 2020—at the end of Hacker's appointment as Leopoldina president—the COVID-19 pandemic thwarted this plan. The interacademy conference, which features top international speakers
are not only significant for further basic research but could also open new avenues for treating COVID-19 and other infectious diseases caused by coronaviruses. In collaboration with the German Societies